The Neuronal Nitric Oxide Synthase Is Upregulated in Mouse Skin Repair and in Response to Epidermal Growth Factor in Human HaCaT Keratinocytes  Jean-Paul.

Slides:



Advertisements
Similar presentations
The Suppressor of Cytokine Signaling-3 Is Upregulated in Impaired Skin Repair: Implications for Keratinocyte Proliferation  Itamar Goren, Andreas Linke,
Advertisements

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities 
MicroRNA-31 Promotes Skin Wound Healing by Enhancing Keratinocyte Proliferation and Migration  Dongqing Li, X.I. Li, Aoxue Wang, Florian Meisgen, Andor.
Cdc42 Inhibits ERK-Mediated Collagenase-1 (MMP-1) Expression in Collagen-Activated Human Keratinocytes  Maryam G. Rohani, Brian K. Pilcher, Peter Chen,
SPINK9 Stimulates Metalloprotease/EGFR–Dependent Keratinocyte Migration via Purinergic Receptor Activation  Maria Sperrhacke, Jan Fischer, Zhihong Wu,
Birgit Stallmeyer, Heiko Kämpfer, Josef Pfeilschifter, Stefan Frank 
Counterregulation of Interleukin-18 mRNA and Protein Expression During Cutaneous Wound Repair in Mice  Heiko Kämpfer, Heiko Mühl, Josef Pfeilschifter,
Impaired Wound Repair in Adult Endoglin Heterozygous Mice Associated with Lower NO Bioavailability  Eduardo Pérez-Gómez, Mirjana Jerkic, Marta Prieto,
Decreased Expression of Caveolin-1 Contributes to the Pathogenesis of Psoriasiform Dermatitis in Mice  Yukie Yamaguchi, Yuko Watanabe, Tomoya Watanabe,
Epidermal Growth Factor Induces Fibronectin Expression in Human Dermal Fibroblasts via Protein Kinase C δ Signaling Pathway  Yoshihiro Mimura, Hironobu.
Insulin-Like Growth Factor-I Enhances Transforming Growth Factor-β-Induced Extracellular Matrix Protein Production Through the P38/Activating Transcription.
Large and Sustained Induction of Chemokines during Impaired Wound Healing in the Genetically Diabetic Mouse: Prolonged Persistence of Neutrophils and.
Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences  Olav Sundnes, Wojciech Pietka,
Interleukin-17 and Interferon-γ Synergize in the Enhancement of Proinflammatory Cytokine Production by Human Keratinocytes  Marcel B.M. Teunissen, Jan.
Matrix Metalloproteinase-19 Expression in Dermal Wounds and by Fibroblasts in Culture  Niina Hieta, Ulla Impola, Carlos López-Otín, Ulpu Saarialho-Kere,
Oncostatin M Expression Is Functionally Connected to Neutrophils in the Early Inflammatory Phase of Skin Repair: Implications for Normal and Diabetes-Impaired.
Regulation of HMG-CoA Synthase and HMG-CoA Reductase by Insulin and Epidermal Growth Factor in HaCaT Keratinocytes  Ian R. Harris, Hendrik Höppner, Wilfried.
Role of aPKC Isoforms and Their Binding Partners Par3 and Par6 in Epidermal Barrier Formation  Iris Helfrich, Annika Schmitz, Paola Zigrino, Christian.
EGFR Regulates the Expression of Keratinocyte-Derived Granulocyte/Macrophage Colony-Stimulating Factor In Vitro and In Vivo  Francesca Mascia, Christophe.
Inhibition of Putative Hyalurosome Platform in Keratinocytes as a Mechanism for Corticosteroid-Induced Epidermal Atrophy  Laurent Barnes, Frédérique Ino,
Histamine Contributes to Tissue Remodeling via Periostin Expression
Stefan W. Stoll, Jessica L. Johnson, Yong Li, Laure Rittié, James T
IL-1R1 Signaling Facilitates Munro’s Microabscess Formation in Psoriasiform Imiquimod-Induced Skin Inflammation  Mireia Uribe-Herranz, Li-Hua Lian, Kirsten.
Coordinated Induction of Inducible Nitric Oxide Synthase and GTP-Cyclohydrolase I Is Dependent on Inflammatory Cytokines and Interferon-γ in HaCaT Keratinocytes:
IGF-II-Mediated COX-2 Gene Expression in Human Keratinocytes Through Extracellular Signal-Regulated Kinase Pathway  Hye Jung Kim, Tae-Yoon Kim  Journal.
Cyclooxygenase-1-Coupled Prostaglandin Biosynthesis Constitutes an Essential Prerequisite for Skin Repair  Heiko Kämpfer, Lutz Bräutigam, Gerd Geisslinger,
Molecular Cloning and Expression of Human Keratinocyte Proline-Rich Protein (hKPRP), an Epidermal Marker Isolated from Calcium-Induced Differentiating.
Expression of Cholesterol Sulfotransferase (SULT2B1b) in Human Skin and Primary Cultures of Human Epidermal Keratinocytes  Yuko Higashi, Hirotoshi Fuda,
EGFR (Trans)activation Mediates IL-8 and Distinct Human Antimicrobial Peptide and Protein Production following Skin Injury  Amanda S. Büchau  Journal.
An Alternatively Spliced IL-15 Isoform Modulates Abrasion-Induced Keratinocyte Activation  Tsung-Lin Lee, Mei-Ling Chang, Yu-Jei Lin, Ming-Hsun Tsai,
Heparin-Binding Epidermal-Growth-Factor-Like Growth Factor Activation of Keratinocyte ErbB Receptors Mediates Epidermal Hyperplasia, a Prominent Side-Effect.
Stromelysin-2 is Upregulated During Normal Wound Repair and is Induced by Cytokines  Oona Rechardt, Maarit Vaalamo, Johanna Höök-Nikanne, Ulpu Saarialho-Kere 
Systemic Anti-TNFα Treatment Restores Diabetes-Impaired Skin Repair in ob/ob Mice by Inactivation of Macrophages  Itamar Goren, Elke Müller, Dana Schiefelbein,
C/EBPγ Regulates Wound Repair and EGF Receptor Signaling
Sustained Activation of Fibroblast Transforming Growth Factor-β/Smad Signaling in a Murine Model of Scleroderma  Shinsuke Takagawa, Gabriella Lakos, Yasuji.
Sema4D, the Ligand for Plexin B1, Suppresses c-Met Activation and Migration and Promotes Melanocyte Survival and Growth  Joanne Soong, Yulin Chen, Elina.
S100A15, an Antimicrobial Protein of the Skin: Regulation by E
Monika Jost, Csaba Kari, Ulrich Rodeck 
Vitamin D Analog Calcipotriol Suppresses the Th17 Cytokine–Induced Proinflammatory S100 “Alarmins” Psoriasin (S100A7) and Koebnerisin (S100A15) in Psoriasis 
Discoidin Domain Receptor 2–microRNA 196a–Mediated Negative Feedback against Excess Type I Collagen Expression Is Impaired in Scleroderma Dermal Fibroblasts 
Anne T. Funding, Claus Johansen, Matthias Gaestel, Bo M
Akt1 Controls Insulin-Driven VEGF Biosynthesis from Keratinocytes: Implications for Normal and Diabetes-Impaired Skin Repair in Mice  Itamar Goren, Elke.
Noritaka Oyama, Keiji Iwatsuki, Yoshimi Homma, Fumio Kaneko 
Ekatherina Vassina, Martin Leverkus, Shida Yousefi, Lasse R
The Function of Nitric Oxide in Wound Repair: Inhibition of Inducible Nitric Oxide- Synthase Severely Impairs Wound Reepithelialization  Birgit Stallmeyer,
Epithelial Overexpression of SOCS-3 in Transgenic Mice Exacerbates Wound Inflammation in the Presence of Elevated TGF-β1  Andreas Linke, Itamar Goren,
Kellie J. White, Vincent J. Maffei, Marvin Newton-West, Robert A
The Suppressor of Cytokine Signaling (SOCS)-3 Determines Keratinocyte Proliferative and Migratory Potential during Skin Repair  Andreas Linke, Itamar.
Reduced Expression of Connective Tissue Growth Factor (CTGF/CCN2) Mediates Collagen Loss in Chronologically Aged Human Skin  TaiHao Quan, Yuan Shao, Tianyuan.
Heiko Kämpfer, Josef Pfeilschifter, Stefan Frank 
Insulin-Like Growth Factor-Binding Protein 7 Regulates Keratinocyte Proliferation, Differentiation and Apoptosis  Janna Nousbeck, Ofer Sarig, Nili Avidan,
Retinoid-Induced Epidermal Hyperplasia Is Mediated by Epidermal Growth Factor Receptor Activation Via Specific Induction of its Ligands Heparin-Binding.
Increased Expression of Wnt2 and SFRP4 in Tsk Mouse Skin: Role of Wnt Signaling in Altered Dermal Fibrillin Deposition and Systemic Sclerosis  Julie Bayle,
Involvement of αvβ5 Integrin in the Establishment of Autocrine TGF-β Signaling in Dermal Fibroblasts Derived from Localized Scleroderma  Yoshihide Asano,
Connective Tissue Growth Factor: Expression in Human Skin In Vivo and Inhibition by Ultraviolet Irradiation  Taihao Quan, Tianyuan He, Sewon Kang, John.
17β-Estradiol Inhibits Oxidative Stress-Induced Apoptosis in Keratinocytes by Promoting Bcl-2 Expression  Naoko Kanda, Shinichi Watanabe  Journal of Investigative.
James Gailit, Mary J. Marchese, Richard R. Kew, Barry L. Gruber 
Inhibition of the Epidermal Growth Factor Receptor Suppresses Telomerase Activity in HSC-1 Human Cutaneous Squamous Cell Carcinoma Cells  Arief Budiyanto,
IL-17A Upregulates Keratin 17 Expression in Keratinocytes through STAT1- and STAT3- Dependent Mechanisms  Xiaowei Shi, Liang Jin, Erle Dang, Ting Chang,
Insulin-Like Growth Factor-II Regulates the Expression of Vascular Endothelial Growth Factor by the Human Keratinocyte Cell Line HaCaT  Yoo-Wook Kwon,
Lawrence M. Pfeffer, Andrzej T. Slominski 
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
John M. Lamar, Vandana Iyer, C. Michael DiPersio 
All-Trans Retinoic Acid Antagonizes UV-Induced VEGF Production and Angiogenesis via the Inhibition of ERK Activation in Human Skin Keratinocytes  Mi-Sun.
Human Leukocyte Elastase Induces Keratinocyte Proliferation by Epidermal Growth Factor Receptor Activation  Ulf Meyer-Hoffert, Jana Wingertszahn, Oliver.
Keratinocyte Apoptosis Induced by Ultraviolet B Radiation and CD95 Ligation – Differential Protection through Epidermal Growth Factor Receptor Activation.
Slug/Snai2 Is a Downstream Mediator of Epidermal Growth Factor Receptor-Stimulated Reepithelialization  Donna F. Kusewitt, Changsun Choi, Kimberly M.
Deon G. Uffort, Elizabeth A. Grimm, Julie A. Ellerhorst 
The Activity of Caspase-1 Is Increased in Lesional Psoriatic Epidermis
Heparin-Binding EGF-Like Growth Factor Is Induced by Disruption of Lipid Rafts and Oxidative Stress in Keratinocytes and Participates in the Epidermal.
Presentation transcript:

The Neuronal Nitric Oxide Synthase Is Upregulated in Mouse Skin Repair and in Response to Epidermal Growth Factor in Human HaCaT Keratinocytes  Jean-Paul Boissel, Dorothea Ohly, Matthias Bros, Ute Gödtel-Armbrust, Ulrich Förstermann, Stefan Frank  Journal of Investigative Dermatology  Volume 123, Issue 1, Pages 132-139 (July 2004) DOI: 10.1111/j.0022-202X.2004.22731.x Copyright © 2004 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 nNOS mRNA expression in human tissues and cells. (a) nNOS exonic organization (exons 13–15). Arrows show the localization of the sense and antisense primers used for PCR amplification. Exonic localization of primers indicate that PCR amplicons (222 bp) must represent expressed nNOS mRNA. (b) Amplifications of nNOS-specific sequences were performed using reverse-transcribed mRNA from human tissues and cells as indicated. nNOS, neuronal nitric oxide synthase. Journal of Investigative Dermatology 2004 123, 132-139DOI: (10.1111/j.0022-202X.2004.22731.x) Copyright © 2004 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 Expression of nNOS upon skin wounding. Regulation of nNOS mRNA (a) and protein (b) expression in BALB/c mice as assessed by real-time PCR or immunoblot. The time after injury is indicated. Ctrl skin represents back skin biopsies of non-wounded mice. A quantification of nNOS mRNA (x-fold induction compared with control skin) is shown in (a). **, p<0.01 (ANOVA) compared with control skin. Bars represent mean±SD obtained from wounds (n=48) isolated from animals (n=12) from three independent animal experiments. RNAs have been equilibrated by analysis of constitutive porphobilinogen deaminase. (b) Total protein (50 μg) from non-wounded control skin and wound tissue was analyzed for nNOS-specific protein. A lysate from murine brain tissue was used as to control the specificity of the used anti-nNOS antiserum. A shorter exposure time of the immunoblot is shown in the right panel. nNOS, neuronal nitric oxide synthase. Journal of Investigative Dermatology 2004 123, 132-139DOI: (10.1111/j.0022-202X.2004.22731.x) Copyright © 2004 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 3 Localization of nNOS protein in regenerating skin. Frozen sections from mouse wounds (day 5 post-wounding) were incubated with a polyclonal antiserum directed against nNOS. Sections were subsequently stained with the avidin–biotin–peroxidase complex system using 3,3-diaminobenzidine tetrahydrochloride as a chromogenic substrate. Nuclei were counterstained with hematoxylin. Immunopositive signals within the sections are indicated with arrows. d, dermis; e, epidermis. nNOS, neuronal nitric oxide synthase. Journal of Investigative Dermatology 2004 123, 132-139DOI: (10.1111/j.0022-202X.2004.22731.x) Copyright © 2004 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 4 Human HaCaT keratinocytes increase nNOS expression upon EGF treatment. (a) Quiescent human HaCaT keratinocytes were stimulated with EGF (100 ng per mL) for 24 h. RNase protection assay to detect nNOS-, eNOS-, or iNOS-specific mRNA was performed as indicated. Ctrl, non-stimulated cells. One representative experiment is shown. β-actin expression is shown as a loading control within the same gel. A quantification of nNOS mRNA (x-fold induction compared with control) over a time period of 24 h as indicated is shown in (b). *, p<0.05; **, p<0.01 (ANOVA) compared with control. Bars indicate the mean±SD obtained from four independent cell culture experiments. (c) Quiescent HaCaT keratinocytes were treated with increasing amounts of EGF for 18 h as indicated. A quantification of nNOS mRNA (x-fold induction compared with control) is shown. **, p<0.01 (ANOVA) compared with control. Bars indicate the mean±SD obtained from four independent cell culture experiments. (d) Total protein (100 μg) from quiescent and EGF-treated (100 ng per mL) HaCaT cells was analyzed for nNOS-specific protein by immunoblot as indicated. Lysate from porcine cerebellum was used to control specificity of the anti-nNOS antiserum. β-tubulin was used as a loading control. One representative experiment is shown. nNOS, neuronal nitric oxide synthase; eNOS, endothelial nitric oxide synthase; iNOS, inducible nitric oxide synthase; EGF, epidermal growth factor. Journal of Investigative Dermatology 2004 123, 132-139DOI: (10.1111/j.0022-202X.2004.22731.x) Copyright © 2004 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 5 Upregulation of nNOS mRNA by ErbB receptor ligands in HaCaT cells. Quiescent human HaCaT keratinocytes were stimulated with EGF, heparin-binding EGF (HB-EGF), heregulin (H)-α, H-β1, or transforming growth factor-α (TGF-α) (100 ng per mL) for 18 h as indicated. RNase protection assay to detect nNOS-specific mRNA was performed. Ctrl, non-stimulated cells. A quantification of nNOS mRNA (x-fold induction compared with control) is shown. **, p<0.01 (ANOVA) compared with control. Bars indicate the mean±SD obtained from four independent cell culture experiments. nNOS, neuronal nitric oxide synthase. Journal of Investigative Dermatology 2004 123, 132-139DOI: (10.1111/j.0022-202X.2004.22731.x) Copyright © 2004 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 6 Expression of activated epidermal growth factor receptor (EGFR) at the wound site. (a) Total protein (50 μg) from non-wounded (ctrl skin) and wounded skin was analyzed for the presence of phosphorylated (Y1173) EGFR-specific protein by immunoblot as indicated. One representative experiment is shown. Frozen sections from mouse wounds isolated at day 5 (b) and day 7 (c) post-wounding were incubated with a polyclonal antiserum directed against phosphorylated (Y1173) EGFR. Sections were subsequently stained with the avidin–biotin–peroxidase complex system using 3,3-diaminobenzidine tetrahydrochloride as a chromogenic substrate. Nuclei were counterstained with hematoxylin. Immunopositive signals within the sections are indicated with arrows. d, dermis; e, epidermis. Journal of Investigative Dermatology 2004 123, 132-139DOI: (10.1111/j.0022-202X.2004.22731.x) Copyright © 2004 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 7 EGFR antagonists inhibit nNOS mRNA expression in HaCaT cells. Quiescent HaCaT keratinocytes were treated with EGF (100 ng per mL) in the presence or absence of increasing amounts of the EGFR antagonist PD153035 (a) or the EGFR/JAK2/3 inhibitor AG490 (b) for 24 h as indicated. RNase protection assay to detect nNOS-specific mRNA was performed. A quantification of nNOS mRNA (x-fold induction compared with control) is shown. **, p<0.01 (ANOVA) compared with control. Bars indicate the mean±SD obtained from four independent cell culture experiments (n=4). EGFR, epidermal growth factor receptor; nNOS, neuronal nitric oxide synthase. Journal of Investigative Dermatology 2004 123, 132-139DOI: (10.1111/j.0022-202X.2004.22731.x) Copyright © 2004 The Society for Investigative Dermatology, Inc Terms and Conditions